High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials

Open Access

Peer-reviewed

Research Article

Qiang Gong,

Affiliation Department of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China
⨯
Lixin Zhou,

Affiliation Department of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China
⨯
Shuangnian Xu,

Affiliation Department of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China
⨯
Xi Li,

Affiliation Department of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China
⨯
Yunding Zou,

Affiliation Department of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China
⨯
Jieping Chen

* E-mail: chenjpxn@163.com

Affiliation Department of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China
⨯

Reader Comments (0)

Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Cytogenetics
Is the Subject Area "Cytogenetics" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Acute myeloid leukemia
Is the Subject Area "Acute myeloid leukemia" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Systematic reviews
Is the Subject Area "Systematic reviews" applicable to this article?

Thanks for your feedback.
Gastrointestinal infections
Is the Subject Area "Gastrointestinal infections" applicable to this article?

Thanks for your feedback.